FACULTY
Jonothan F Dickens, MD
Asante Bio Paid consultant for a company/supplier
Sparta Unpaid consultant for company/supplier
Restor3d Unpaid consultant for company/supplier
RevBio Unpaid consultant for company/supplier
Brett D. Owens, MD
ConMed Linvatec Royalties from a company/supplier
DePuy Mitek Royalties from a company/supplier
SAGE Publications Royalties from a company/supplier
AOSSM Royalties from med/ortho publishers
Spinger Royalties from med/ortho publishers
Slack Royalties from med/ortho publishers
Elsevie Royalties from med/ortho publishers
James P. Bradley, MD
Arthrex, Inc. Royalties from a company/supplier
Arthrex, Inc. Speakers bureau/honorarium payment
Arthrex, Inc. Paid consultant for a company/supplier
DJO Global, Inc Unpaid consultant for company/supplier
Matthew T. Provencher, MD, MBA
Arthrex, Inc. Royalties from a company/supplier
Athrosurface, Inc Royalties from a company/supplier
Elsevier, Inc. Royalties from a company/supplier
SLACK, Inc. Royalties from a company/supplier
Arthrex, Inc. Paid consultant for a company/supplier
Arthrex, Inc. Research support from company/supplier
JRF Research support from company/supplier
BUMED Research support from company/supplier
NIH Research support from company/supplier
OREF Research support from company/supplier
DoD Research support from company/supplier
SLACK Incorporated Royalties from med/ortho publishers
Elsevier, Inc. Royalties from med/ortho publishers
Lance E. LeClere, MD
Arthrex, Inc. Paid consultant for a company/supplier
Vericel Paid consultant for a company/supplier
Ossio Research support from company/supplier
Eiji Itoi, MD
has no relevant financial relationship(s) with ineligible companies to disclose
Justin Arner, MD
has no relevant financial relationship(s) with ineligible companies to disclose
PLANNERS
Donna Tilton
Nothing to disclose
Christina Ortega
Nothing to disclose
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, we have implemented measures to identify and mitigate relevant financial relationships. All individuals in control of content have disclosed their financial relationships with ineligible companies within the past 24 months. These relationships have been reviewed and mitigated.
ORIGINAL RELEASE DATE: 4/2/2026
TERMINATION DATE:4/1/2029